| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | 0.037 | 0.2 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | NSC-87877 | GDSC1000 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | JQ-1:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | Roscovitine | FIMM | pan-cancer | AAC | -0.2 | 0.2 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |